Next Generation Proteomics and Drug Sensitivity Resistance Testing Allow for the Identification of Distinct Sub-clones of Multiple Myeloma Patients
2019
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI